Umoja Biopharma

Umoja Biopharma is pioneering in vivo CAR T cell therapies, focusing on improving cancer treatment by generating CAR T cells directly in patients' bodies using their VivoVec platform

Biotech & Life Sciences

Sector

Seed

Stage

Biotechnology

Model

01Company Overview

Umoja Biopharma is pioneering in vivo CAR T cell therapies, focusing on improving cancer treatment by generating CAR T cells directly in patients' bodies using their VivoVec platform.

02Backed By1 investor

WCWRF Capital→

03Similar Companies